Short description
Syndexa Pharmaceuticals develops drugs to treat metabolic diseases.
Description
Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to treat metabolic diseases. Founded by scientists from Harvard University, and led by President and CEO Teo Uysal, Syndexa is dedicated to the discovery and development of a new generation of small-molecule drugs targeting novel mechanisms for the treatment and prevention of diseases of endoplasmic reticulum (ER) dysfunction which include inflammatory and metabolic diseases and disorders, cardiovascular diseases and neurodegenerative diseases. The company has raised $24.8m of equity capital to date.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Watertown, Massachusetts, United States, North America
Founded on
January 1, 2005
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccess, Noaccess
Sign in for full access
Founders
Teo Uysal